Point Of Care Medical Imaging Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Point-of-care medical imaging refers to diagnostic imaging technologies, including ultrasound, X-ray, computed tomography, and magnetic resonance imaging, that can be deployed at or near the patient rather than in centralized radiology departments. The global market reached approximately $44 billion in 2025 and is valued at roughly $46.2 billion in 2026, with a projected compound annual growth rate of 5.0% over the forecast horizon. Growth at this pace reflects broadening clinical adoption across acute care settings, outpatient facilities, and emerging point-of-care diagnostics applications.

• •The broader medical imaging market, of which point-of-care is a significant and growing segment, is projected to reach between $74 billion and $102 billion by the early 2030s depending on the forecast horizon.
• •The U.S. point-of-care medical imaging segment alone is estimated at over $311 million in 2025, with projections approaching $498 million in coming years, indicating robust domestic demand.
• •Point-of-care ultrasound represents one of the fastest-growing technology categories within the segment, driven by its portability, decreasing cost, and expanding clinical applications.

Several interrelated macro trends are fueling market expansion, including rising prevalence of chronic and lifestyle-related diseases, an aging global population, and increasing healthcare infrastructure investment across emerging economies. The shift toward minimally invasive and value-based care models incentivizes early and accurate diagnosis at the bedside, reducing costly hospital admissions and improving patient throughput. Additionally, ongoing miniaturization of imaging hardware and improvements in battery technology, wireless connectivity, and artificial intelligence-assisted image interpretation are lowering barriers to adoption in resource-constrained settings.

• •Aging demographics in developed and developing nations are increasing demand for portable imaging in long-term care, nursing homes, and home health environments.
• •Post-pandemic investments in decentralized and telehealth-capable diagnostic infrastructure have accelerated procurement of point-of-care imaging systems.
• •AI-powered image analysis and cloud-based diagnostic workflows are expanding the clinical utility of compact imaging devices beyond traditional radiology settings.

The market is commonly segmented by product type, including ultrasound systems, X-ray and CT devices, and MRI systems, as well as by end-use setting, encompassing hospitals, ambulatory surgical centers, diagnostic imaging centers, and home care. Geographically, North America and Europe currently account for the largest share of market revenue due to advanced healthcare infrastructure, favorable reimbursement frameworks, and high technology adoption rates. The Asia-Pacific region is expected to post the strongest growth trajectory over the forecast period, driven by expanding hospital construction, rising per-capita healthcare spending, and government initiatives to modernize diagnostic capabilities.

• •North America held a dominant position in the point-of-care imaging segment at the start of the forecast period, supported by high device penetration and an established regulatory pathway for novel imaging technologies.
• •The Asia-Pacific market is forecast to grow at the fastest pace among all regions, reflecting hospital bed expansion, growing medical tourism, and domestic manufacturing capabilities.
• •Within end-use segmentation, hospitals and critical care units remain the largest consumer segment, though demand from physician offices and home-based care settings is growing at an accelerating rate.

Who are the notable companies in the industry?

The point-of-care medical imaging industry exhibits a competitive structure that ranges from highly consolidated in certain mature product categories to moderately fragmented in emerging technology segments. The market features a mix of large diversified medical device producers with broad imaging portfolios and specialized manufacturers focused exclusively on portable or handheld imaging technologies. Technology routes in the segment center on miniaturized transducer and sensor arrays, solid-state detector technologies for X-ray and CT, and increasingly on software-defined imaging platforms leveraging artificial intelligence for image enhancement and automated interpretation.

• •The industry sits along a spectrum between consolidated and fragmented, with mature modalities like conventional X-ray showing fewer, larger players while handheld ultrasound and compact MRI segments remain more open to new entrants.
• •Technology differentiation primarily revolves around device portability, image quality relative to full-size systems, connectivity and interoperability with electronic health records, and integrated AI-assisted diagnostic tools.
• •Regional manufacturing capacity is heavily concentrated in established medical device hubs in North America, Western Europe, Japan, and parts of East Asia, with capacity expansion increasingly oriented toward serving the Asia-Pacific and Latin American markets.

What are the recent trends and outlook?

Over the medium term, the market is expected to sustain a 5.0% annual growth rate through the forecast period, with adoption driven by continued clinical validation of point-of-care imaging for new indications and expanding reimbursement coverage. Integration with telehealth platforms and electronic health record ecosystems is anticipated to deepen, enabling remote image review and specialist consultation from any care setting. Advances in solid-state sensor technology, battery efficiency, and edge-computing-based AI are likely to further reduce the size and cost of imaging systems while maintaining diagnostic-grade image quality.

• •AI-augmented imaging workflows and automated diagnostic assistance are expected to become standard features in next-generation point-of-care devices, potentially reshaping competitive positioning.
• •Regulatory and reimbursement policy shifts in major markets, particularly expanded coverage for bedside imaging in outpatient and home care settings, could unlock additional adoption growth beyond baseline projections.
• •Emerging technology platforms, including handheld molecular imaging and compact MRI systems, may create new market sub-segments and incremental demand over the longer forecast horizon.